Need Help?

Sequencing data for rare tumors and sarcomas

This dataset contains DNA and RNA sequencing information for AML, Gliomas, brain tumors (medulloblastoma and ependymoma), DIPG, rhabdoid tumors and soft tissue sarcomas. In total 39 samples are present (14 matched normal, 25 tumor samples). Not all samples have matched normals and not all samples have RNA sequencing data..

Request Access

Data access policy

DATA ACCESS AGREEMENT These terms and conditions govern access to the managed access datasets to which the User Institution has requested access. The User Institution agrees to be bound by these terms and conditions. Definitions Authorised Personnel: The individuals at the User Institution to whom the Children’s Cancer Therapy Development Institute (cc-TDI) grants access to the Data. This includes the User and any other individuals for whom the User Institution subsequently requests access to the Data. Data: The managed access datasets to which the User Institution has requested access. Data Producers: cc-TDI and collaborators responsible for the development, organisation, and oversight of these Data. External Collaborator: A collaborator of the User, working for an institution other than the User Institution. Project: The project for which the User Institution has requested access to these Data. Publications: Includes, without limitation, articles published in print journals, electronic journals, reviews, books, posters and other written and verbal presentations of research. Research Participant: An individual whose data form part of these Data. Research Purposes: Shall mean research that is seeking to advance the understanding of genetics and genomics, including the treatment of disorders, and work on statistical methods that may be applied to such research. User: The principal investigator for the Project. User Institution(s): The Institution that has requested access to the Data. 1. The User Institution agrees to only use these Data for the purpose of the Project and only for Research Purposes. The User Institution further agrees that it will only use these Data for Research Purposes which are within the limitations (if any) set out in Appendix I. 2. The User Institution agrees to preserve, at all times, the confidentiality of these Data. In particular, it undertakes not to use, or attempt to use these Data to compromise or otherwise infringe the confidentiality of information on Research Participants. Without prejudice to the generality of the foregoing, the User Institution agrees to use at least the measures set out in Appendix I to protect these Data. 3. The User Institution agrees to protect the confidentiality of Research Participants in any research papers or publications that they prepare by taking all reasonable care to limit the possibility of identification. 4. The User Institution agrees not to link or combine these Data to other information or archived data available in a way that could re-identify the Research Participants, even if access to that data has been formally granted to the User Institution or is freely available without restriction. 5. The User Institution agrees only to transfer or disclose these Data, in whole or part, or any material derived from these Data, to the Authorised Personnel. Should the User Institution wish to share these Data with an External Collaborator, the External Collaborator must complete a separate application for access to these Data. 6. The User Institution agrees that the Data Producers, and all other parties involved in the creation, funding or protection of these Data: a) make no warranty or representation, express or implied as to the accuracy, quality or comprehensiveness of these Data; b) exclude to the fullest extent permitted by law all liability for actions, claims, proceedings, demands, losses (including but not limited to loss of profit), costs, awards damages and payments made by the Recipient that may arise (whether directly or indirectly) in any way whatsoever from the Recipient’s use of these Data or from the unavailability of, or break in access to, these Data for whatever reason and; c) bear no responsibility for the further analysis or interpretation of these Data. 7. The User Institution agrees to follow the Fort Lauderdale Guidelines (http://www.wellcome.ac.uk/stellent/groups/corporatesite/@policy_communications/documents/web_document/wtd003207.pdf ) and the Toronto Statement (http://www.nature.com/nature/journal/v461/n7261/full/461168a.html). This includes but is not limited to recognising the contribution of the Data Producers and including a proper acknowledgement in all reports or publications resulting from the use of these Data. 8. The User Institution agrees not to make intellectual property claims on these Data and not to use intellectual property protection in ways that would prevent or block access to, or use of, any element of these Data, or conclusion drawn directly from these Data. 9. The User Institution can elect to perform further research that would add intellectual and resource capital to these data and decide to obtain intellectual property rights on these downstream discoveries. In this case, the User Institution agrees to implement licensing policies that will not obstruct further research and to follow the U.S. National Institutes of Health Best Practices for the Licensing of Genomic Inventions (2005) (https://www.icgc.org/files/daco/NIH_BestPracticesLicensingGenomicInventions_2005_en.pdf ) in conformity with the Organisation for Economic Co-operation and Development Guidelines for the Licensing of the Genetic Inventions (2006) (http://www.oecd.org/science/biotech/36198812.pdf ). 10. The User Institution agrees to destroy/discard the Data held, once it is no longer used for the Project, unless obliged to retain the data for archival purposes in conformity with audit or legal requirements. 11. The User Institution will notify cc-TDI within 30 days of any changes or departures of Authorised Personnel. 12. The User Institution will notify cc-TDI prior to any significant changes to the protocol for the Project. 13. The User Institution will notify cc-TDI as soon as it becomes aware of a breach of the terms or conditions of this agreement. 14. cc-TDI may terminate this agreement by written notice to the User Institution. If this agreement terminates for any reason, the User Institution will be required to destroy any Data held, including copies and backup copies. This clause does not prevent the User Institution from retaining these data for archival purpose in conformity with audit or legal requirements. 15. The User Institution accepts that it may be necessary for the Data Producers to alter the terms of this agreement from time to time. As an example, this may include specific provisions relating to the Data required by Data Producers other than cc-TDI. In the event that changes are required, the Data Producers or their appointed agent will contact the User Institution to inform it of the changes and the User Institution may elect to accept the changes or terminate the agreement. 16. If requested, the User Institution will allow data security and management documentation to be inspected to verify that it is complying with the terms of this agreement. 17. The User Institution agrees to distribute a copy of these terms to the Authorised Personnel. The User Institution will procure that the Authorised Personnel comply with the terms of this agreement. 18. This agreement (and any dispute, controversy, proceedings or claim of whatever nature arising out of this agreement or its formation) shall be construed, interpreted and governed by the laws of England and Wales and shall be subject to the exclusive jurisdiction of the English courts. APPENDIX I – DATASET DETAILS Specific limitations on areas of research No limitations for use of data so long as no attempt is made to identify the original subjects associated with the de-identified patient samples Minimum protection measures required Data should not be shared to other research groups or research institutions. Data access by new requesters should be made through EGA . File access: Data can be held in unencrypted files on an institutional compute system, with Unix user group read/write access for one or more appropriate groups but not Unix world read/write access behind a secure firewall. Laptops holding these data should have password protected logins and screenlocks (set to lock after 5 min of inactivity). If held on USB keys or other portable hard drives, the data must be encrypted.

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
EGAS00001006351 Other
EGAS00001006352 Other
EGAS00001006353 Other
EGAS00001006354 Other
EGAS00001006355 Other
EGAS00001006356 Cancer Genomics

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Located in
EGAF00006211485 fq.gz 5.8 GB
EGAF00006211486 fq.gz 5.9 GB
EGAF00006211487 fq.gz 5.2 GB
EGAF00006211488 fq.gz 5.4 GB
EGAF00006211489 fq.gz 4.9 GB
EGAF00006211490 fq.gz 5.0 GB
EGAF00006211491 fq.gz 5.1 GB
EGAF00006211492 fq.gz 5.2 GB
EGAF00006211493 fq.gz 5.2 GB
EGAF00006211494 fq.gz 5.4 GB
EGAF00006211495 fq.gz 4.8 GB
EGAF00006211496 fq.gz 4.9 GB
EGAF00006211497 fq.gz 4.7 GB
EGAF00006211498 fq.gz 4.8 GB
EGAF00006211499 fq.gz 6.2 GB
EGAF00006211500 fq.gz 6.4 GB
EGAF00006211501 fq.gz 5.2 GB
EGAF00006211502 fq.gz 5.3 GB
EGAF00006211503 fq.gz 5.3 GB
EGAF00006211504 fq.gz 5.2 GB
EGAF00006211505 fq.gz 3.8 GB
EGAF00006211506 fq.gz 3.9 GB
EGAF00006211507 fq.gz 6.1 GB
EGAF00006211508 fq.gz 6.0 GB
EGAF00006211509 fq.gz 6.4 GB
EGAF00006211510 fq.gz 6.3 GB
EGAF00006211511 fq.gz 6.3 GB
EGAF00006211512 fq.gz 6.1 GB
EGAF00006211513 fq.gz 6.2 GB
EGAF00006211514 fq.gz 6.0 GB
EGAF00006211515 fq.gz 39.5 GB
EGAF00006211516 fq.gz 42.7 GB
EGAF00006211517 fq.gz 98.4 GB
EGAF00006211518 fq.gz 104.1 GB
EGAF00006211519 fq.gz 8.2 GB
EGAF00006211520 fq.gz 8.5 GB
EGAF00006211521 fq.gz 6.2 GB
EGAF00006211522 fq.gz 6.0 GB
EGAF00006211523 fq.gz 3.3 GB
EGAF00006211524 fq.gz 3.4 GB
EGAF00006211525 fq.gz 6.1 GB
EGAF00006211526 fq.gz 6.2 GB
EGAF00006211527 fq.gz 4.1 GB
EGAF00006211528 fq.gz 4.1 GB
EGAF00006211529 fq.gz 3.3 GB
EGAF00006211530 fq.gz 3.3 GB
EGAF00006211531 fq.gz 6.0 GB
EGAF00006211532 fq.gz 6.0 GB
EGAF00006211533 fq.gz 3.8 GB
EGAF00006211534 fq.gz 3.7 GB
EGAF00006211535 fq.gz 6.0 GB
EGAF00006211536 fq.gz 6.0 GB
EGAF00006211537 fq.gz 5.9 GB
EGAF00006211538 fq.gz 5.9 GB
EGAF00006211539 fq.gz 5.1 GB
EGAF00006211540 fq.gz 5.1 GB
EGAF00006211541 fq.gz 3.8 GB
EGAF00006211542 fq.gz 3.8 GB
EGAF00006211543 fq.gz 6.0 GB
EGAF00006211544 fq.gz 5.9 GB
EGAF00006211545 fq.gz 5.9 GB
EGAF00006211546 fq.gz 5.9 GB
EGAF00006211547 fq.gz 4.0 GB
EGAF00006211548 fq.gz 3.8 GB
EGAF00006211549 fq.gz 5.9 GB
EGAF00006211550 fq.gz 5.8 GB
EGAF00006211551 fq.gz 3.9 GB
EGAF00006211552 fq.gz 3.9 GB
EGAF00006211553 fq.gz 5.9 GB
EGAF00006211554 fq.gz 5.9 GB
EGAF00006211555 fq.gz 3.9 GB
EGAF00006211556 fq.gz 4.0 GB
EGAF00006211557 fq.gz 3.0 GB
EGAF00006211558 fq.gz 3.1 GB
EGAF00006211559 fq.gz 3.0 GB
EGAF00006211560 fq.gz 3.1 GB
EGAF00006211561 fq.gz 3.8 GB
EGAF00006211562 fq.gz 3.9 GB
EGAF00006211563 fq.gz 6.2 GB
EGAF00006211564 fq.gz 6.4 GB
EGAF00006211565 fq.gz 6.5 GB
EGAF00006211566 fq.gz 6.5 GB
EGAF00006211567 fq.gz 3.9 GB
EGAF00006211568 fq.gz 4.0 GB
EGAF00006211569 fq.gz 6.4 GB
EGAF00006211570 fq.gz 6.4 GB
EGAF00006211571 fq.gz 5.9 GB
EGAF00006211572 fq.gz 5.9 GB
EGAF00006211573 fq.gz 3.7 GB
EGAF00006211574 fq.gz 3.8 GB
EGAF00006211575 fq.gz 6.0 GB
EGAF00006211576 fq.gz 5.6 GB
EGAF00006211577 fq.gz 5.9 GB
EGAF00006211578 fq.gz 5.5 GB
EGAF00006211579 fq.gz 3.8 GB
EGAF00006211580 fq.gz 3.8 GB
EGAF00006211581 fq.gz 6.1 GB
EGAF00006211582 fq.gz 6.0 GB
EGAF00006211583 fq.gz 6.0 GB
EGAF00006211584 fq.gz 6.0 GB
EGAF00006211585 fq.gz 3.7 GB
EGAF00006211586 fq.gz 3.7 GB
102 Files (789.7 GB)